For research teamsHelp me find a study
Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1909studies shown
Showing 1,153-1,164 of 1,909
Drug study icon
CompletedNCT00314821

Ropinirole in the Treatment of Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Atlanta
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 64 Years
Countries
United States
Sponsor
Cambridge Health Alliance
Condition
Bipolarity, Depression
View study
Device study icon
WithdrawnNCT00447096

rTMS for Treatment of Depressed Phase of Bipolarity type II

This summary needs review. Please check the official study record and contact the research team for details.

In Dallas
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Bipolarity, Depression
View study
Drug study icon
WithdrawnNCT00359125

RU-486 in the Treatment of Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Vancouver
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 19 Years to 65 Years
Countries
Canada
Sponsor
University of British Columbia
Condition
Bipolarity, Depression
View study
Drug study icon
CompletedNCT00852202

Safety and Efficacy of RGH-188 (Cariprazine) in Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Encino
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Forest Laboratories
Condition
Bipolarity, Depression
View study
Drug study icon
CompletedNCT00060489

Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Depression for depression in bipolarity

This study is completed in the United States. It is testing Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Depression for depression in bipolarity.

Multiple locations, including Birmingham
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
AstraZeneca
Condition
Bipolarity, Depression
View study
Drug study icon
TerminatedNCT01122927

Safety study of aripiprazole in schizophrenia

This study was terminated in the United States, in Bulgaria, in Croatia, .... It is testing aripiprazole for schizophrenia.

Multiple locations, including Dothan
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, SchizophreniaDrugFrom 10 Years to 17 Years
Countries
United States, Bulgaria, Croatia, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity, Schizophrenia
View study
Drug study icon
CompletedNCT01396447

Safety study of safety, Tolerability, and Efficacy of Cariprazine in Participants With Depression in depression in bipolarity

This study is completed in the United States, in Canada, in Bulgaria, .... It is testing safety, Tolerability, and Efficacy of Cariprazine in Participants With Depression for depression in bipolarity.

Multiple locations, including Birmingham
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Canada, Bulgaria, ...
Sponsor
Forest Laboratories
Condition
Bipolarity, Depression
View study
Drug study icon
CompletedNCT04211961

Scopolamine in Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Galway
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugOver 18 Years
Countries
Ireland
Sponsor
Dr. Brian Hallahan
Condition
Bipolarity, Depression
View study
Other study type icon
CompletedNCT02253225

Self Focus in Bipolarity: A Functional Magnetic Resonance Imaging (fMRI) Study

This summary needs review. Please check the official study record and contact the research team for details.

In Boston
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 64 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Bipolarity, Depression
View study
Drug study icon
CompletedNCT02974010

Sequential Therapy for Severe Depression in bipolarity.

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Birmingham
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, Depression, ...DrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
NeuroRx, Inc.
Condition
Bipolarity, Depression, ...
View study
Drug study icon
TerminatedNCT01665950

Simvastatin Augmentation of Lithium Treatment in Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Boston
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Bipolarity, Depression
View study
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.